Pharmafile Logo

Rob Jones

KVA header image and David Rowley

Healthcare services entrepreneur David Rowley joins KVA

KVA appoints David Rowley to act as advisor to the board

KVA

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

M3 (EU)

- PMLiVE

Moderna applies to FDA for authorisation for second COVID-19 booster shot for all adults

The second booster shot would be for adults 18 years and over who have already had one authorised COVID-19 booster shot

- PMLiVE

CBI launches new Health Council as part of its Seize The Moment 2030 vision

The CEO forum has been designed to bring together business, government and civil society to improve health outcomes across the UK

OPEN Health - David Thompson

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

OPEN Health

- PMLiVE

AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris

The two companies will withdraw patent infringement proceedings filed with the US and Japan

- PMLiVE

Merck KGaA to make $3m payout to patients after drug formulation complaints

La Cour de Cassation has ordered the company to make the payment to more than 3,000 patients to settle the reformulation dispute

Top 10 Ways that Medical Affairs Team Can Leverage the Impetus Insite Platform

New to asynchronous touchpoints? Don’t know where to start? Need help designing an asynchronous event that will engage your stakeholders and give you the insights you’re looking for? In addition...

Impetus Digital

Digitalizing Self-Care to Empower Patients

Jonathon Carr-Brown, Chief Operating Officer at Healthily, shares how they are redefining the relationship between retailers and over-the-counter pharmaceutical companies with their customers, and how a digitally-enabled Pre-Primary Care Health...

Impetus Digital

- PMLiVE

MHRA grants approval for AstraZeneca’s Evusheld in the UK

It is the first antibody combination treatment authorised for use before exposure to COVID-19 infection in order to prevent disease licensed in the UK

Biogen Idec building

Biogen shares peer-reviewed publication of Aduhelm phase 3 data

The trial data was published in The Journal of Prevention of Alzheimer’s Disease

The Price of Drugs – The Cost of LIVING

With increasing drug prices, what is the true cost to society? (Article written 2nd December 2020)

Dice Medical Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links